Literature DB >> 12750769

Gender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly-diagnosed diabetes.

G Hu1.   

Abstract

AIM/HYPOTHESIS: Diabetic women generally have a greater relative risk of cardiovascular diseases than diabetic men in comparison with non-diabetic women and men. Reasons for this excess risk in diabetic women is still unclear. The aim of this study is to evaluate whether the association between different degrees of hyperglycaemia and the risk of all-cause and cardiovascular mortality is different in women and men.
METHODS: We analysed baseline glucose concentrations from 14 prospective European cohorts including 8172 men and 9407 women aged 30 to 89 years without history of diabetes, with a median follow-up of 8.3 years. Hazards ratios for all-cause and cardiovascular mortality were estimated adjusting for other risk factors.
RESULTS: The mortality rates for all-cause and cardiovascular diseases were higher in men than in women in normoglycaemia, impaired glucose regulation and newly-diagnosed diabetes; the largest sex differential for cardiovascular mortality was in normoglycaemic people. The hazards ratios for all-cause and cardiovascular mortality were higher in newly-diagnosed diabetic women than men compared with normoglycaemic women and men, respectively; however, this sex difference was only significant for cardiovascular mortality. For smokers and for subjects with hypertension, hypercholesterolaemia or who where overweight, the hazards ratios for cardiovascular mortality in diabetic patients compared with normoglycaemic people were also higher in women than in men. CONCLUSIONS/
INTERPRETATION: Newly diagnosed diabetic women showed higher relative risks for death from cardiovascular disease than diabetic men. Thus a more aggressive control of hyperglycaemia as well as of other cardiovascular risk factors might be appropriate in women with asymptomatic hyperglycaemia.

Entities:  

Mesh:

Year:  2003        PMID: 12750769     DOI: 10.1007/s00125-003-1096-6

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  23 in total

1.  Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.

Authors:  J D Curb; S L Pressel; J A Cutler; P J Savage; W B Applegate; H Black; G Camel; B R Davis; P H Frost; N Gonzalez; G Guthrie; A Oberman; G H Rutan; J Stamler
Journal:  JAMA       Date:  1996-12-18       Impact factor: 56.272

2.  Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators.

Authors:  J Tuomilehto; D Rastenyte; W H Birkenhäger; L Thijs; R Antikainen; C J Bulpitt; A E Fletcher; F Forette; A Goldhaber; P Palatini; C Sarti; R Fagard
Journal:  N Engl J Med       Date:  1999-03-04       Impact factor: 91.245

3.  Fasting proinsulin concentrations predict the development of type 2 diabetes.

Authors:  N J Wareham; C D Byrne; R Williams; N E Day; C N Hales
Journal:  Diabetes Care       Date:  1999-02       Impact factor: 19.112

4.  Sex differences in fasting glycemia as a risk factor for ischemic heart disease death.

Authors:  C Scheidt-Nave; E Barrett-Connor; D L Wingard; B A Cohn; S L Edelstein
Journal:  Am J Epidemiol       Date:  1991-03-15       Impact factor: 4.897

Review 5.  The impact of gender and general risk factors on the occurrence of atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus.

Authors:  T J Orchard
Journal:  Ann Med       Date:  1996-08       Impact factor: 4.709

6.  Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria.

Authors: 
Journal:  Arch Intern Med       Date:  2001-02-12

7.  Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in Finland.

Authors:  P Jousilahti; E Vartiainen; J Tuomilehto; P Puska
Journal:  Circulation       Date:  1999-03-09       Impact factor: 29.690

8.  Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women.

Authors:  W H Pan; L B Cedres; K Liu; A Dyer; J A Schoenberger; R B Shekelle; R Stamler; D Smith; P Collette; J Stamler
Journal:  Am J Epidemiol       Date:  1986-03       Impact factor: 4.897

9.  Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group.

Authors: 
Journal:  BMJ       Date:  1998-08-08

10.  A prospective population based study of gender differential in mortality from cardiovascular disease and "all causes" in asymptomatic hyperglycaemics.

Authors:  M Janghorbani; R B Jones; W H Gilmour; A J Hedley; M Zhianpour
Journal:  J Clin Epidemiol       Date:  1994-04       Impact factor: 6.437

View more
  35 in total

1.  Mesenteric arterial dysfunction in the UC Davis Type 2 Diabetes Mellitus rat model is dependent on pre-diabetic versus diabetic status and is sexually dimorphic.

Authors:  Sonali Shaligram; Farjana Akther; Md Rahatullah Razan; James L Graham; Núria Roglans; Marta Alegret; Arta Gharib Parsa; Kimber L Stanhope; Peter J Havel; Roshanak Rahimian
Journal:  Eur J Pharmacol       Date:  2020-04-19       Impact factor: 4.432

2.  Gender difference in rat aorta vasodilation after acute exposure to high glucose: involvement of protein kinase C beta and superoxide but not of Rho kinase.

Authors:  Aditya Goel; Yingmin Zhang; Leigh Anderson; Roshanak Rahimian
Journal:  Cardiovasc Res       Date:  2007-07-04       Impact factor: 10.787

Review 3.  Prandial glucose regulation in the glucose triad: emerging evidence and insights.

Authors:  Paul Beisswenger; Robert J Heine; Lawrence A Leiter; Alan Moses; Jaakko Tuomilehto
Journal:  Endocrine       Date:  2004-12       Impact factor: 3.633

4.  Determinants of normoglycemia and contribution to cardiovascular risk factors in a Chinese population: the Hong Kong Cardiovascular Risk Factor Study.

Authors:  G Neil Thomas; S M McGhee; C M Schooling; S Y Ho; K S L Lam; E D Janus; T H Lam
Journal:  J Endocrinol Invest       Date:  2006-06       Impact factor: 4.256

5.  Postpartum dyslipidaemia in women diagnosed with gestational diabetes mellitus.

Authors:  A C O'Higgins; Vicky O'Dwyer; Clare O'Connor; Sean F Daly; Brendan T Kinsley; Michael J Turner
Journal:  Ir J Med Sci       Date:  2016-07-11       Impact factor: 1.568

6.  The effect of diabetes and stroke at baseline and during follow-up on stroke mortality.

Authors:  G Hu; P Jousilahti; C Sarti; R Antikainen; J Tuomilehto
Journal:  Diabetologia       Date:  2006-08-01       Impact factor: 10.122

Review 7.  Gender disparity in outcomes of care and management for diabetes and the metabolic syndrome.

Authors:  Pantelis A Sarafidis; Samy I McFarlane; George L Bakris
Journal:  Curr Diab Rep       Date:  2006-06       Impact factor: 4.810

Review 8.  Type 2 diabetes mellitus and hypertension: an update.

Authors:  Guido Lastra; Sofia Syed; L Romayne Kurukulasuriya; Camila Manrique; James R Sowers
Journal:  Endocrinol Metab Clin North Am       Date:  2013-12-12       Impact factor: 4.741

9.  Plasma insulin and cardiovascular mortality in non-diabetic European men and women: a meta-analysis of data from eleven prospective studies.

Authors: 
Journal:  Diabetologia       Date:  2004-07-07       Impact factor: 10.122

10.  Postchallenge glucose, A1C, and fasting glucose as predictors of type 2 diabetes and cardiovascular disease: a 10-year prospective cohort study.

Authors:  Henna Cederberg; Tuula Saukkonen; Mauri Laakso; Jari Jokelainen; Pirjo Härkönen; Markku Timonen; Sirkka Keinänen-Kiukaanniemi; Ulla Rajala
Journal:  Diabetes Care       Date:  2010-06-23       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.